Intermedine

DB17612InvestigationalProtein Based Therapies

Intermedine: Overview.

Mechanism: Pharmacologically active on Melanocyte-stimulating hormone receptor, Melanocortin receptor 4, and Melanocortin receptor 3
Curator reviewed
Also known as: .alpha.-melanocyte-stimulating hormone · .alpha.-melanotropin · .alpha.-melanotropin (human) · .alpha.-melanotropin (ox) · .alpha.-melanotropin (sheep)
Code names: MSH

Resolves to

Compound

Targets

What you can answer from here — as of September 12, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Intermedine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.